Test Directory
| Test Code | |||
| WNVSF | |||
| Test Name | |||
| West Nile Virus RNA, Cerebrospinal Fluid | |||
| CPT Codes | |||
| 87798 | |||
| Expected Turnaround Time | |||
| 1 - 5 days | |||
| Clinical Utility | |||
|
Rapid testing for West Nile virus (WNV) RNA (lineage 1 and lineage 2) using cerebrospinal fluid specimens. An adjunctive test to serology for detection of early WNV infection (ie, first few days after symptom onset). This assay should not be used for screening asymptomatic individuals and should only be used to test patients with signs and symptoms of WNV disease. |
|||
| Specimen and Container Info | |||
|
Specimen Type: Cerebrospinal Fluid
Collection Container: Sterile, Non-Additive Container (CSF) Desired Specimen Volume: 0.5 mL |
|||
| Collection Instructions | |||
|
|||
| Processing and Submission Instructions | |||
|
|||
| Transport Instructions | |||
|
Transport to the laboratory refrigerated. |
|||
| Stability Requirements | |||
|
|||
| Causes for Rejection | |||
|
|||
| Methodology | |||
| Real Time Polymerase Chain Reaction | |||
| Reference Intervals | |||
|
See patient report. |
|||
| Limitations | |||
|
A negative test does not exclude infection with West Nile virus. Therefore, the results obtained should be used in conjunction with clinical findings and serologic test results to make an accurate diagnosis. This assay detects both viable and nonviable virus. Test performance depends on viral load in the specimen and may not correlate with cell culture performed on the same specimen. |
|||
| Alternate Names | |||
|
|||
| Reference Lab | |||
| Mayo Clinic Laboratories | |||
| Testing Schedule | |||
| Monday-Friday | |||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.